Published in Clin Cancer Res on July 01, 2008
Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas. Pediatr Blood Cancer (2012) 1.15
CXCR4 activation defines a new subgroup of Sonic hedgehog-driven medulloblastoma. Cancer Res (2011) 1.09
Receptor tyrosine kinases as therapeutic targets in rhabdomyosarcoma. Sarcoma (2011) 0.92
The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation. Cell Death Dis (2013) 0.86
Alveolar rhabdomyosarcoma - The molecular drivers of PAX3/7-FOXO1-induced tumorigenesis. Skelet Muscle (2012) 0.85
Selective upregulation of interleukin-8 by human rhabdomyosarcomas in response to hypoxia: therapeutic implications. Int J Cancer (2010) 0.83
Understanding the Interplay between Expression, Mutation and Activity of ALK Receptor in Rhabdomyosarcoma Cells for Clinical Application of Small-Molecule Inhibitors. PLoS One (2015) 0.80
The role of chemokine receptor CXCR4 in the biologic behavior of human soft tissue sarcoma. Sarcoma (2010) 0.79
Inhibition of metastasis of rhabdomyosarcoma by a novel neutralizing antibody to CXC chemokine receptor-4. Cancer Sci (2014) 0.78
Analysis of molecular cytogenetic alteration in rhabdomyosarcoma by array comparative genomic hybridization. PLoS One (2014) 0.78
Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression. Oncotarget (2015) 0.78
Expression of chemokine receptors on peripheral blood T cells in children with chronic kidney disease. Mediators Inflamm (2015) 0.75
Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One (2008) 3.68
TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells. Cell Cycle (2011) 2.41
Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group. J Clin Oncol (2005) 2.26
Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol (2006) 2.24
Surviving childhood cancer. Hosp Med (2002) 2.01
Renal function adaptation in children with unilateral renal tumors treated with nephron sparing surgery or nephrectomy. J Urol (2005) 1.78
Local lymph node involvement in pediatric renal cell carcinoma: a report from the Italian TREP project. Pediatr Blood Cancer (2008) 1.52
Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68. Cancer Res (2009) 1.52
MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. FASEB J (2009) 1.51
Fibrinogen storage disease caused by Aguadilla mutation presenting with hypobeta-lipoproteinemia and considerable liver disease. J Pediatr Gastroenterol Nutr (2009) 1.50
Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma. Cell Cycle (2009) 1.50
Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine. Transplantation (2004) 1.49
Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma. J Clin Oncol (2003) 1.47
CD44-v6 expression in smooth muscle cells in the postnatal remodeling process of ductus arteriosus. Am J Cardiol (2006) 1.38
RAS signaling dysregulation in human embryonal Rhabdomyosarcoma. Genes Chromosomes Cancer (2009) 1.36
Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma. Cancer Res (2002) 1.36
Severe hepatotoxicity during combination antiretroviral treatment: incidence, liver histology, and outcome. J Acquir Immune Defic Syndr (2003) 1.28
Malignant pancreatic endocrine tumor in a child with tuberous sclerosis. Am J Surg Pathol (2003) 1.21
Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical models. Clin Cancer Res (2008) 1.18
Expression of Slug is regulated by c-Myb and is required for invasion and bone marrow homing of cancer cells of different origin. J Biol Chem (2010) 1.16
Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma. Cancer (2005) 1.16
Unresectable multifocal omental and peritoneal inflammatory myofibroblastic tumor in a child: revisiting the role of adjuvant therapy. J Pediatr Surg (2011) 1.14
Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J Immunol (2004) 1.12
Inhibiting interactions of lysine demethylase LSD1 with snail/slug blocks cancer cell invasion. Cancer Res (2012) 1.11
Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule. Int J Radiat Oncol Biol Phys (2002) 1.08
Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age-period-cohort models. Int J Cancer (2005) 1.07
Addiction of MYCN amplified tumours to B-MYB underscores a reciprocal regulatory loop. Oncotarget (2010) 1.07
Chemotherapy and surgery in children with cystic echinococcosis. Pediatr Infect Dis J (2010) 1.05
Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells. J Mol Cell Cardiol (2004) 1.05
Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo. Clin Cancer Res (2006) 1.04
Inflammatory myofibroblastic tumors in childhood: a report from the Italian Cooperative Group studies. Cancer (2010) 1.04
Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation. J Cell Physiol (2006) 1.04
Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: results of a pilot study on 239 patients. Clin Cancer Res (2008) 1.03
Preserved antibody levels and loss of memory B cells against pneumococcus and tetanus after splenectomy: tailoring better vaccination strategies. Eur J Immunol (2013) 1.02
Mature and immature teratomas: results of the first paediatric Italian study. Pediatr Surg Int (2007) 1.02
Differential detection of PAS-positive inclusions formed by the Z, Siiyama, and Mmalton variants of alpha1-antitrypsin. Hepatology (2004) 1.01
Treatment of Wilson's disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study. J Lab Clin Med (2005) 1.00
Long-term outcome of nephron sparing surgery and simple nephrectomy for unilateral localized Wilms tumor. J Urol (2005) 1.00
Synergistic post-transcriptional regulation of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) by miR-101 and miR-494 specific binding. PLoS One (2011) 0.99
Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis (2011) 0.99
A multicenter, randomized, double blind placebo-controlled trial of amoxicillin/clavulanate for the prophylaxis of fever and infection in neutropenic children with cancer. Pediatr Infect Dis J (2003) 0.96
Synovial sarcoma of children and adolescents: the prognostic role of axial sites. Eur J Cancer (2008) 0.96
Elevated levels of miR-145 correlate with SMAD3 down-regulation in cystic fibrosis patients. J Cyst Fibros (2013) 0.96
Elongation Factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility. Mol Cancer (2009) 0.95
Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model. Int J Cancer (2009) 0.95
Expression of insulin-like growth factor-binding protein 5 in neuroblastoma cells is regulated at the transcriptional level by c-Myb and B-Myb via direct and indirect mechanisms. J Biol Chem (2002) 0.94
c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571. Int J Cancer (2003) 0.94
Activation of miR200 by c-Myb depends on ZEB1 expression and miR200 promoter methylation. Cell Cycle (2013) 0.93
Conservative management of hyperplastic and multicentric nephroblastomatosis. J Urol (2004) 0.93
Kidney function following nephrectomy during childhood: response to Timsit et al., Urol Oncol 2012. Urol Oncol (2013) 0.93
Expression of the lipogenic enzyme fatty acid synthase (FAS) in retinoblastoma and its correlation with tumor aggressiveness. Invest Ophthalmol Vis Sci (2003) 0.93
Peliosis hepatis as an early histological finding in idiopathic portal hypertension: A case report. World J Gastroenterol (2006) 0.92
Sacrococcygeal teratoma--a 25-year experience in a UK regional center. J Pediatr Surg (2006) 0.92
Rhabdomyosarcoma in adolescents: a report from the AIEOP Soft Tissue Sarcoma Committee. Cancer (2011) 0.92
Nephroblastoma: multidrug-resistance P-glycoprotein expression in tumor cells and intratumoral capillary endothelial cells. Am J Clin Pathol (2002) 0.91
Recurrent metanephric stromal tumor in an infant. Urology (2011) 0.91
A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience. J Neurooncol (2008) 0.91
Sensenbrenner syndrome: a new member of the hepatorenal fibrocystic family. Am J Med Genet A (2006) 0.90
Surgical interventions for the treatment of radiation-induced alopecia in pediatric practice. Pediatr Blood Cancer (2007) 0.90
Asymptomatic congenital cystic adenomatoid malformation of the lung: is it time to operate? J Thorac Cardiovasc Surg (2009) 0.90
Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members. BMC Cancer (2014) 0.89
Serologic and genetic markers of celiac disease: a sequential study in the screening of first degree relatives. J Pediatr Gastroenterol Nutr (2006) 0.89
Mechanisms of interleukin-6 protection against ischemia-reperfusion injury in rat liver. Cytokine (2006) 0.89
High mobility group A1 is a molecular target for MYCN in human neuroblastoma. Cancer Res (2005) 0.89
Prognostic factors in pleuro-pulmonary blastoma. Pediatr Blood Cancer (2007) 0.89
MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response. Mol Cancer Res (2010) 0.88
Radiofrequency thermoablation in chest wall mesenchymal hamartoma of an infant. Ann Thorac Surg (2007) 0.88
Bronchial adenoma: an unusual cause of recurrent pneumonia in childhood. Ann Thorac Surg (2003) 0.88
Complete second look operation and radiotherapy in locally advanced non-alveolar rhabdomyosarcoma in children: A report from the AIEOP soft tissue sarcoma committee. Pediatr Blood Cancer (2008) 0.88
A new ABCB11 mutation in two Italian children with familial intrahepatic cholestasis. J Gastroenterol (2006) 0.88
Up-regulation of EphB and ephrin-B expression in rhabdomyosarcoma. Anticancer Res (2008) 0.88
B cell clonality in multiple localizations of primary central nervous system lymphomas in AIDS patients. Leuk Lymphoma (2003) 0.88